JP Morgan Chase’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21 | Hold |
13
| – | – | ﹤0.01% | 7406 |
|
|
2025
Q4 | $26 | Sell |
13
-565,426
| -100% | -$1.81M | ﹤0.01% | 7286 |
|
|
2025
Q3 | $1.65M | Sell |
565,439
-191,622
| -25% | -$441K | ﹤0.01% | 4223 |
|
|
2025
Q2 | $1.37M | Sell |
757,061
-32,955
| -4% | -$58.6K | ﹤0.01% | 4190 |
|
|
2025
Q1 | $1.19M | Buy |
790,016
+388,681
| +97% | +$981K | ﹤0.01% | 4235 |
|
|
2024
Q4 | $947K | Buy |
401,335
+364,982
| +1,004% | +$6.41M | ﹤0.01% | 4669 |
|
|
2024
Q3 | $1.07M | Sell |
36,353
-19,524
| -35% | -$450K | ﹤0.01% | 4425 |
|
|
2024
Q2 | $690K | Buy |
55,877
+3
| +0% | +$63 | ﹤0.01% | 4503 |
|
|
2024
Q1 | $1.13M | Buy |
55,874
+745
| +1% | +$17.2K | ﹤0.01% | 4253 |
|
|
2023
Q4 | $1.24M | Buy |
55,129
+5,926
| +12% | +$125K | ﹤0.01% | 4190 |
|
|
2023
Q3 | $819K | Sell |
49,203
-6,417
| -12% | -$127K | ﹤0.01% | 4190 |
|
|
2023
Q2 | $1.36M | Buy |
55,620
+6,013
| +12% | +$145K | ﹤0.01% | 3819 |
|
|
2023
Q1 | $1.2M | Buy |
49,607
+10,242
| +26% | +$284K | ﹤0.01% | 3916 |
|
|
2022
Q4 | $1.16M | Buy |
39,365
+4,239
| +12% | +$152K | ﹤0.01% | 3939 |
|
|
2022
Q3 | $1.47M | Sell |
35,126
-20,740
| -37% | -$560K | ﹤0.01% | 3723 |
|
|
2022
Q2 | $1.57M | Buy |
55,866
+27,148
| +95% | +$686K | ﹤0.01% | 3735 |
|
|
2022
Q1 | $1.07M | Buy |
28,718
+4,123
| +17% | +$175K | ﹤0.01% | 4219 |
|
|
2021
Q4 | $1.07M | Buy |
24,595
+1,546
| +7% | +$81.1K | ﹤0.01% | 4339 |
|
|
2021
Q3 | $1.43M | Sell |
23,049
-2,808
| -11% | -$234K | ﹤0.01% | 4043 |
|
|
2021
Q2 | $2.21M | Sell |
25,857
-22,776
| -47% | -$1.22M | ﹤0.01% | 3726 |
|
|
2021
Q1 | $2.19M | Buy |
48,633
+34,122
| +235% | +$1.34M | ﹤0.01% | 3656 |
|
|
2020
Q4 | $99K | Buy |
14,511
+5,871
| +68% | +$52.4K | ﹤0.01% | 4998 |
|
|
2020
Q3 | $99K | Buy |
8,640
+845
| +11% | +$3.81K | ﹤0.01% | 4697 |
|
|
2020
Q2 | $24K | Buy |
+7,795
| New | +$35.4K | ﹤0.01% | 5004 |
|
|
2019
Q3 | – | Sell |
-13,743
| Closed | -$17K | – | 5924 |
|
|
2019
Q2 | $17K | Buy |
+13,743
| New | +$15.6K | ﹤0.01% | 5476 |
|
|
2014
Q4 | – | Sell |
-3,404
| Closed | -$93K | – | 4340 |
|
|
2014
Q3 | $93K | Sell |
3,404
-628
| -16% | -$19.1K | ﹤0.01% | 4092 |
|
|
2014
Q2 | $163K | Sell |
4,032
-2,170
| -35% | -$80.3K | ﹤0.01% | 3404 |
|
|
2014
Q1 | $239K | Buy |
6,202
+2,798
| +82% | +$98.8K | ﹤0.01% | 3365 |
|
|
2013
Q4 | $116K | Sell |
3,404
-18
| -0.5% | -$478 | ﹤0.01% | 3884 |
|
|
2013
Q3 | $65K | Sell |
3,422
-170
| -5% | -$2.97K | ﹤0.01% | 4233 |
|
|
2013
Q2 | $56K | Buy |
+3,592
| New | +$75.9K | ﹤0.01% | 4258 |
|
Other funds holding FLNA
VCM
GC
JP Morgan Chase's FLNA Position: Q1 2026 in Review
JP Morgan Chase held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 13 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #7406.
JP Morgan Chase first reported a position in FLNA in Q2 2013 and has held it in 31 quarters since. The position peaked at $2.21M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- JP Morgan Chase held 13 shares of Filana Therapeutics worth $21 as of Q1 2026.
- JP Morgan Chase left its Filana Therapeutics share count unchanged in Q1 2026.
- Filana Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7406 holding.
- JP Morgan Chase first reported a position in Filana Therapeutics in Q2 2013 and has held it in 31 quarters since.
- JP Morgan Chase's Filana Therapeutics position peaked at $2.21M in Q2 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.